[1]
Alexandros Charalabopoulos and Theodoros Liakakos 2017. Dysadherin: A Novel Oncogenic Molecular Biomarker in Oesophageal Cancer. Cancer Studies and Molecular Medicine . 3, 2 (Jul. 2017), e5-e6.